TrialThe oncologist2016

Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.

Lawrence Leichman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.